The Role of Vericiguat for Treatment of Heart Failure With Reduced Ejection Fraction.
Journal articles
- Editorial
Greene, SJ; Butler, J
Published in: J Card Fail
March 17, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Card Fail
DOI
EISSN
1532-8414
Publication Date
March 17, 2026
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Greene, S. J., & Butler, J. (2026). The Role of Vericiguat for Treatment of Heart Failure With Reduced Ejection Fraction. J Card Fail. https://doi.org/10.1016/j.cardfail.2026.02.039
Greene, Stephen J., and Javed Butler. “The Role of Vericiguat for Treatment of Heart Failure With Reduced Ejection Fraction.” J Card Fail, March 17, 2026. https://doi.org/10.1016/j.cardfail.2026.02.039.
Greene SJ, Butler J. The Role of Vericiguat for Treatment of Heart Failure With Reduced Ejection Fraction. J Card Fail. 2026 Mar 17;
Greene, Stephen J., and Javed Butler. “The Role of Vericiguat for Treatment of Heart Failure With Reduced Ejection Fraction.” J Card Fail, Mar. 2026. Pubmed, doi:10.1016/j.cardfail.2026.02.039.
Greene SJ, Butler J. The Role of Vericiguat for Treatment of Heart Failure With Reduced Ejection Fraction. J Card Fail. 2026 Mar 17;
Published In
J Card Fail
DOI
EISSN
1532-8414
Publication Date
March 17, 2026
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology